Sirtuins in neurodegenerative diseases: An update on potential mechanisms

Frontiers in Aging Neuroscience

Volumn 5, Issue SEP, 2013, Pages

  Min, Sang Won ^a,b   Sohn, Peter D ^a   Cho, Seo Hyun ^a,b   Swanson, Raymond A ^a   Gan, Li ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid ; Epigenetic regulation; Inflammation; Mitochondria; Neurodegeneration; NF B; SIRT1; Tau

Indexed keywords

DNA; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7;

BRAIN MITOCHONDRION; CELL AGING; CHRONIC INFLAMMATION; CLINICAL FEATURE; DEGENERATIVE DISEASE; DNA METHYLATION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; MOLECULAR DYNAMICS; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN HOMEOSTASIS; REGULATORY MECHANISM; REVIEW;

EID: 84895817637     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00053     Document Type: Review

References (105)

1. Adler, A. S., Kawahara, T. L., Segal, E., and Chang, H. Y. (2008). Reversal of aging by NFkappaB blockade. Cell Cycle 7, 556-569. doi: 10.4161/cc.7.5.5490.
2. Adler, A. S., Sinha, S., Kawahara, T. L., Zhang, J. Y., Segal, E., and Chang, H. Y. (2007). Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 21, 3244-3257. doi: 10.1101/gad.1588507.
3. Albani, D., Polito, L., Batelli, S., De Mauro, S., Fracasso, C., Martelli, G., et al. (2009). The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J. Neurochem. 110, 1445-1456. doi: 10.1111/j.1471-4159.2009.06228.x.
4. Alberini, C. M., Ghirardi, M., Metz, R., and Kandel, E. R. (1994). C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76, 1099-114. doi: 10.1016/0092-8674(94)90386-7.
5. Amat, R., Planavila, A., Chen, S. L., Iglesias, R., Giralt, M., and Villarroya, F. (2009). SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-{gamma} co-activator-1{alpha} (PGC-1{alpha}) gene in skeletal muscle through the PGC-1{alpha} autoregulatory loop and interaction with MyoD. J. Biol. Chem. 284, 21872-21880. doi: 10.1074/jbc. M109.022749.
6. Andersen, J. K. (2004). Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10(Suppl.) S18-S25. doi: 10.1038/nrn1434.
7. Bai, P., Canto, C., Oudart, H., Brunyanszki, A., Cen, Y., Thomas, C., et al. (2011). PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461-468. doi: 10.1016/j.cmet.2011.03.004.
8. Banerjee, K. K., Ayyub, C., Ali, S. Z., Mandot, V., Prasad, N. G., and Kolthur-Seetharam, U. (2012). dSir2 in the adult fat body, but not in muscles, regulates life span in a diet-dependent manner. Cell Rep. 2, 1485-1491. doi: 10.1016/j.celrep.2012.11.013.
9. Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G., and de Cabo, R. (2012). Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug Discov. 11, 443-461. doi: 10.1038/nrd3738.
10. Beneke, S. (2012). Regulation of chromatin structure by poly(ADP-ribosyl)ation. Front. Genet. 3:169. doi: 10.3389/fgene.2012.00169.
11. Berg, L., McKeel, D. W. Jr., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., et al. (1998). Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch. Neurol. 55, 326-335. doi: 10.1001/archneur.55.3.326.
12. Bernstein, B. E., Meissner, A., and Lander, E. S. (2007). The mammalian epigenome. Cell 128, 669-681. doi: 10.1016/j.cell.2007.01.033.
13. Bliss, T. V., and Collingridge, G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39. doi: 10.1038/361031a0.
14. Brenmoehl, J., and Hoeflich, A. (2013). Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrion. doi: 10.1016/j.mito.2013.04.002 [Epub ahead of print].
15. Burnett, C., Valentini, S., Cabreiro, F., Goss, M., Somogyvari, M., and Piper, M. D. (2011). Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485. doi: 10.1038/nature10296.
16. Cairns, N. J., Bigio, E. H., Mackenzie, I. R., Neumann, M., Lee, V. M., Hatanpaa, K. J., et al. (2007). Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol. 114, 5-22. doi: 10.1007/s00401-007-0237-2.
17. Canto, C., Sauve, A. A., and Bai, P. (2013). Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol. Aspects Med. doi: 10.1016/j.mam.2013.01.004 [Epub ahead of print].
18. Cao, S. X., Dhahbi, J. M., Mote, P. L., and Spindler, S. R. (2001). Genomic profiling of short-and long-term caloric restriction effects in the liver of aging mice. Proc. Natl. Acad. Sci. U.S.A. 98, 10630-10635. doi: 10.1073/pnas.191313598.
19. Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L. F., Kwon, H., and Yi, S. (2005). SIRT1 protects against microglia-dependent amyloid-{beta} toxicity through inhibiting NF-{kappa}B signaling. J. Biol. Chem. 280, 40364-40374. doi: 10.1074/jbc. M509329200.
20. Chen, L. F., and Greene, W. C. (2003). Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med. (Berl.) 81, 549-57. doi: 10.1007/s00109-003-0469-0.
21. Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., and Trojanowski, J. Q. (2011). The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat. Commun. 2, 252. doi: 10.1038/ncomms1255.
22. Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., and Krainc, D. (2006). Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69. doi: 10.1016/j.cell.2006.09.015.
23. Day, J. J., and Sweatt, J. D. (2011). Epigenetic mechanisms in cognition. Neuron 70, 813-829. doi: 10.1016/j.neuron.2011.05.019.
24. Donmez, G., Arun, A., Chung, C. Y., McLean, P. J., Lindquist, S., and Guarente, L. (2012). SIRT1 protects against alpha-synuclein aggregation by activating molecular chaperones. J. Neurosci. 32, 124-132. doi: 10.1523/JNEUROSCI.3442-11.2012.
25. Donmez, G., and Outeiro, T. F. (2013). SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol. Med. 5, 344-352. doi: 10.1002/emmm.201302451.
26. Donmez, G., Wang, D., Cohen, D. E., and Guarente, L. (2010). SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142, 320-332. doi: 10.1016/j.cell.2010.06.020.
27. Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., et al. (2011). Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809. doi: 10.1126/science.1207861.
28. Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., and Tsai, L. H. (2007). Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178-182. doi: 10.1038/nature05772.
29. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., and Guarente, L. (2006). Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080. doi: 10.1101/gad.1399706.
30. Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., et al. (2007). Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92-105. doi: 10.1016/j.mad.2006.11.016.
31. Frye, R. A. (2000). Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-798. doi: 10.1006/bbrc.2000.3000.
32. Fu, J., Jin, J., Cichewicz, R. H., Hageman, S. A., Ellis, T. K., Xiang, L., et al. (2012). Trans-(-)-epsilon-viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington disease. J. Biol. Chem. 287, 24460-24472. doi: 10.1074/jbc. M112.382226.
33. Fusco, S., Ripoli, C., Podda, M. V., Ranieri, S. C., Leone, L. G., Toietta, M. W., et al. (2012). A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 109, 621-626. doi: 10.1073/pnas.1109237109.
34. Gal, J., Bang, Y., and Choi, H. J. (2012). SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition. Neurochem. Int. 61, 992-1000. doi: 10.1016/j.neuint.2012.07.010.
35. Gao, J., Wang, W. Y., Mao, Y. W., Graff, J., Guan, J. S., Pan, L., et al. (2010). A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466, 1105-1109. doi: 10.1038/nature09271.
36. Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., and Gage, F. H. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934. doi: 10.1016/j.cell.2010.02.016.
37. Goedert, M., Spillantini, M. G., Del Tredici, K., and Braak, H. (2013). 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13-24. doi: 10.1038/nrneurol.2012.242.
38. Grinberg, L. T., Wang, X., Wang, C., Sohn, P. D., Theofilas, P., Sidhu, M., et al. (2013). Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation. Acta Neuropathol. 125, 581-593. doi: 10.1007/s00401-013-1080-2.
39. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994.
40. Hartnett, L., and Egan, L. J. (2012). Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 33, 723-731. doi: 10.1093/carcin/bgs006.
41. Hashimoto, K., Otero, M., Imagawa, K., de Andres, M. C., Coico, J. M., Roach, R. O., et al. (2013). Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1beta (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem. 288, 10061-10072. doi: 10.1074/jbc. M112.421156.
42. Hayden, M. S., and Ghosh, S. (2012). NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26, 203-234. doi: 10.1101/gad.183434.111.
43. Hynd, M. R., Scott, H. L., and Dodd, P. R. (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45, 583-595. doi: 10.1016/j.neuint.2004.03.007.
44. Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., Xie, S. X., and Lee, V. M. (2012). Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 135, 807-818. doi: 10.1093/brain/aws013.
45. Jeong, H., Cohen, D. E., Cui, L., Supinski, A., Savas, J. N., Mazzulli, J. R., et al. (2012). Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 18, 159-165. doi: 10.1038/nm.2559.
46. Jeong, J. K., Moon, M. H., Lee, Y. J., Seol, J. W., and Park, S. Y. (2013). Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiol. Aging 34, 146-156. doi: 10.1016/j.neurobiolaging.2012.04.002.
47. Jia, G., Su, L., Singhal, S., and Liu, X. (2012). Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging. Mol. Cell. Biochem. 364, 345-350. doi: 10.1007/s11010-012-1236-8.
48. Jiang, M., Wang, J., Fu, J., Du, L., Jeong, H., West, T., et al. (2012). Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat. Med. 18, 153-8. doi: 10.1038/nm.2558.
49. Jonsson, T. H., Stefansson, S., Steinberg, I., Jonsdottir, P. V., Jonsson, J., Snaedal, S., et al. (2013). Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116. doi: 10.1056/NEJMoa1211103.
50. Julien, C., Tremblay, C., Emond, V., Lebbadi, M., Salem, N. Jr., Bennett, D. A., et al. (2009). Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 68, 48-58. doi: 10.1097/NEN.0b013e3181922348.
51. Kabe, Y., Ando, K., Hirao, S., Yoshida, M., and Handa, H. (2005). Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 7, 395-403. doi: 10.1089/ars.2005.7.395.
52. Kaeberlein, M., McVey, M., and Guarente, L. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580. doi: 10.1101/gad.13.19.2570.
53. Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., Nahum, L., et al. (2012). The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218-221. doi: 10.1038/nature10815.
54. Kauppinen, T. M., Gan, L., and Swanson, R. A. (2013). Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-kappaB transcriptional activity by preventing p65 de-acetylation. Biochim. Biophys. Acta 1833, 1985-1991. doi: 10.1016/j.bbamcr.2013.04.005.
55. Kawahara, T. L., Michishita, E., Adler, A. S., Damian, M., Berber, E., Lin, M., et al. (2009). SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136, 62-74. doi: 10.1016/j.cell.2008.10.052.
56. Kenyon, C. J. (2010). The genetics of ageing. Nature 464, 504-512. doi: 10.1038/nature08980.
57. Kim, S. H., Lu, H. F., and Alano, C. C. (2011). Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture. PLoS ONE 6:e14731. doi: 10.1371/journal.pone.0014731.
58. Klein, W. L. (2002). Ab toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41, 345-352. doi: 10.1016/S0197-0186(02)00050-5.
59. Krstic, D., and Knuesel, I. (2013). Deciphering the mechanism underlying late-onset Alzheimer disease. Nat. Rev. Neurol. 9, 25-34. doi: 10.1038/nrneurol.2012.236.
60. Lee, I. H., Cao, L., Mostoslavsky, R., Lombard, D. B., Liu, J., Bruns, N. E., et al. (2008). A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 105, 3374-3379. doi: 10.1073/pnas.0712145105.
61. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., et al. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357. doi: 10.1038/nature04533.
62. Levine, B., and Kroemer, G. (2008). Autophagy in the pathogenesis of disease. Cell 132, 27-42. doi: 10.1016/j.cell.2007.12.018.
63. Libert, S., and Guarente, L. (2013). Metabolic and neuropsychiatric effects of calorie restriction and sirtuins. Annu. Rev. Physiol. 75, 669-684. doi: 10.1146/annurev-physiol-030212-183800.
64. Lin, M. T., and Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. doi: 10.1038/nature05292.
65. Lipsky, R. H., and Marini, A. M. (2007). Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann. N.Y. Acad. Sci. 1122, 130-143. doi: 10.1196/annals.1403.009.
66. Liu, T. F., Yoza, B. K., El Gazzar, M., Vachharajani, V. T., and McCall, C. E. (2011). NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 286, 9856-9864. doi: 10.1074/jbc. M110.196790.
67. Lombard, D. B., Alt, F. W., Cheng, H. L., Bunkenborg, J., Streeper, R. S., Mostoslavsky, R., et al. (2007). Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27, 8807-8814. doi: 10.1128/MCB.01636-07.
68. Lu, T., Pan, Y., Kao, S. Y., Li, C., Kohane, I., Chan, J., et al. (2004). Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891. doi: 10.1038/nature02661.
69. Ludolph, A. C., Kassubek, J., Landwehrmeyer, B. G., Mandelkow, E., Mandelkow, E. M., Burn, D. J., et al. (2009). Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur. J. Neurol. 16, 297-309. doi: 10.1111/j.1468-1331.2008.02513.x.
70. Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., and Reddy, P. H. (2006). Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437-1449. doi: 10.1093/hmg/ddl066.
71. Mattson, M. P., and Meffert, M. K. (2006). Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13, 852-860. doi: 10.1038/sj.cdd.4401837.
72. McCall, C. E., El Gazzar, M., Liu, T., Vachharajani, V., and Yoza, B. (2011). Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J. Leukoc. Biol. 90, 439-446. doi: 10.1189/jlb.0211075.
73. Medzhitov, R., and Horng, T. (2009). Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9, 692-703. doi: 10.1038/nri2634.
74. Michan, S., and Sinclair, D. (2007). Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13. doi: 10.1042/BJ20070140.
75. Min, S. W., Cho, S. H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., et al. (2010). Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953-966. doi: 10.1016/j.neuron.2010.08.044.
76. Newman, J. C., He, W., and Verdin, E. (2012). Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J. Biol. Chem. 287, 42436-42443. doi: 10.1074/jbc. R112.404863.
77. Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., et al. (2007). Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317, 516-519. doi: 10.1126/science.1143780.
78. Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., and Catoire, H. (2005). Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37, 349-350. doi: 10.1038/ng1534.
79. Peng, L., Yuan, Z., Ling, H., Fukasawa, K., Robertson, K., Olashaw, N., et al. (2011). SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol. Cell. Biol. 31, 4720-4734. doi: 10.1128/MCB.06147-11.
80. Qiang, L., Lin, H. V., Kim-Muller, J. Y., Welch, C. L., Gu, W., and Accili, D. (2011). Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab. 14, 758-767. doi: 10.1016/j.cmet.2011.10.007.
81. Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., et al. (2006). Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281, 21745-21754. doi: 10.1074/jbc. M602909200.
82. Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., and Chen, D. (2010). Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 12, 662-667. doi: 10.1016/j.cmet.2010.11.015.
83. Querfurth, H. W., and LaFerla, F. M. (2010). Alzheimer's disease. N. Engl. J. Med. 362, 329-344. doi: 10.1056/NEJMra0909142.
84. Rajamohan, S. B., Pillai, V. B., Gupta, M., Sundaresan, N. R., Birukov, K. G., and Samant, S. (2009). SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol. Cell. Biol. 29, 4116-4129. doi: 10.1128/MCB.00121-09.
85. Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., and Puigserver, P. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118. doi: 10.1038/nature03354.
86. Rogina, B., and Helfand, S. L. (2004). Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 101, 15998-16003. doi: 10.1073/pnas.0404184101.
87. Rovillain, E., Mansfield, L., Caetano, C., Alvarez-Fernandez, M., Caballero, O. L., Medema, R. H., et al. (2011). Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30, 2356-2366. doi: 10.1038/onc.2010.611.
88. Saccani, S., and Natoli, G. (2002). Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev. 16, 2219-2224. doi: 10.1101/gad.232502.
89. Sampaio-Marques, B., Felgueiras, C., Silva, A., Rodrigues, M., Tenreiro, S., Franssens, V., et al. (2012). SNCA (alpha-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy. Autophagy 8, 1494-1509. doi: 10.4161/auto.21275.
90. Schug, T. T., Xu, Q., Gao, H., Peres da Silva, A., Draper, D. W., Fessler, M. B., et al. (2010). Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol. Cell. Biol. 30, 4712-4721. doi: 10.1128/MCB.00657-10.
91. Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., et al. (2010). Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802-812. doi: 10.1016/j.cell.2010.10.002.
92. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jager, S., et al. (2006). Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408. doi: 10.1016/j.cell.2006.09.024.
93. Tanzi, R. E., and Bertram, L. (2005). Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555. doi: 10.1016/j.cell.2005.02.008.
94. Tilstra, J. S., Robinson, A. R., Wang, J., Gregg, S. Q., Clauson, C. L., Reay, D. P., et al. (2012). NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122, 2601-2612. doi: 10.1172/JCI45785.
95. Tissenbaum, H. A., and Guarente, L. (2001). Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230. doi: 10.1038/35065638.
96. van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M., Plasterk, R. H., and Nollen, E. A. (2008). C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 4:e1000027. doi: 10.1371/journal.pgen.1000027.
97. Vaquero, A., Scher, M., Erdjument-Bromage, H., Tempst, P., Serrano, L., and Reinberg, D. (2007). SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 450, 440-444. doi: 10.1038/nature06268.
98. Verdin, E., Hirschey, M. D., Finley, L. W., and Haigis, M. C. (2010). Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem. Sci. 35, 669-675. doi: 10.1016/j.tibs.2010.07.003.
99. Viswanathan, M., and Guarente, L. (2011). Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes. Nature 477, E1-E2. doi: 10.1038/nature10440.
100. Wang, W., Kwon, E. J., and Tsai, L. H. (2012). MicroRNAs in learning, memory, and neurological diseases. Learn. Mem. 19, 359-368. doi: 10.1101/lm.026492.112.
101. Weir, H. J., Murray, T. K., Kehoe, P. G., Love, S., Verdin, E. M., O'Neill, M. J., et al. (2012). CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PLoS ONE 7:e48225. doi: 10.1371/journal.pone.0048225.
102. Westerheide, S. D., Anckar, J., Stevens, S. M. Jr., Sistonen, L., and Morimoto, R. I. (2009). Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323, 1063-1066. doi: 10.1126/science.1165946.
103. Wu, Y., Li, X., Zhu, J. X., Xie, W., Le, W., Fan, Z., et al. (2011). Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals 19, 163-174. doi: 10.1159/000328516.
104. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., et al. (2004). Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380. doi: 10.1038/sj.emboj.7600244.
105. Zocchi, L., and Sassone-Corsi, P. (2012). SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression. Epigenetics 7, 695-700. doi: 10.4161/epi.20733.